1.1.1.19: glucuronate reductase
This is an abbreviated version!
For detailed information about glucuronate reductase, go to the full flat file.
Word Map on EC 1.1.1.19
-
1.1.1.19
-
aldo-keto
-
aldose
-
sorbinil
-
akr1b1s
-
o-quinones
-
alrestatin
-
1.1.1.21
-
daunorubicinol
-
trans-dihydrodiols
-
statil
-
akr7a2
-
dl-glyceraldehyde
-
3alpha-hydroxysteroid
-
diol-epoxide
- 1.1.1.19
-
aldo-keto
- aldose
- sorbinil
- akr1b1s
- o-quinones
- alrestatin
-
1.1.1.21
- daunorubicinol
-
trans-dihydrodiols
- statil
-
akr7a2
- dl-glyceraldehyde
-
3alpha-hydroxysteroid
-
diol-epoxide
Reaction
Synonyms
AKR1A1, aldehyde reductase, aldehyde reductase II, ALR1, D-glucuronate dehydrogenase, D-glucuronate reductase, D-glucuronic reductase, galacturonate oxidoreductase, hexonate dehydrogenase, L-glucuronate reductase, L-gulonate NAD-3-oxidoreductase, L-hexonate:NADP dehydrogenase, More, NADP-L-gulonate dehydrogenase, PcGOR, TPN l-hexonate dehydrogenase, TPN-L-gulonate dehydrogenase
ECTree
Advanced search results
Disease
Disease on EC 1.1.1.19 - glucuronate reductase
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Acute Kidney Injury
Metabolic reprogramming by the S-nitroso-CoA reductase system protects against kidney injury.
Anemia
Association between the genetic polymorphisms of the pharmacokinetics of anthracycline drug and myelosuppression in a patient with breast cancer with anthracycline-based chemotherapy.
Ascorbic Acid Deficiency
A novel osteoporosis model with ascorbic acid deficiency in Akr1A1 gene knockout mice.
Astrocytoma
The role of aldehyde reductase AKR1A1 in the metabolism of gamma-hydroxybutyrate in 1321N1 human astrocytoma cells.
Astrocytoma
[Effect of AKR1A1 knock-down on H2;O2; and 4-hydroxynonenal-induced cytotoxicity in human 1321N1 astrocytoma cells].
Breast Neoplasms
Association between the genetic polymorphisms of the pharmacokinetics of anthracycline drug and myelosuppression in a patient with breast cancer with anthracycline-based chemotherapy.
Carcinoma, Hepatocellular
Metabolism of gamma hydroxybutyrate in human hepatoma HepG2 cells by the aldo-keto reductase AKR1A1.
Diabetes Mellitus, Type 2
Activities of aldose reductase, ATPases, and nucleotide concentrations of erythrocytes in patients with type 2 (non-insulin-dependent) diabetes mellitus.
Laryngeal Neoplasms
Increased aldehyde reductase expression mediates acquired radioresistance of laryngeal cancer cells via modulating p53.
Liver Diseases, Alcoholic
Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members.
Lymphoma, Non-Hodgkin
Genetic Polymorphisms in Oxidative Stress Pathway Genes and Modification of BMI and Risk of Non-Hodgkin Lymphoma.
Neoplasms
Quantitative analysis of the human AKR family members in cancer cell lines using the mTRAQ/MRM approach.
Neoplasms
The role of cytochromes p450 and aldo-keto reductases in prognosis of breast carcinoma patients.
Osteoporosis
A novel osteoporosis model with ascorbic acid deficiency in Akr1A1 gene knockout mice.
html completed